Skip to main content

Correction: MiR-21 regulating PVT1/PTEN/IL-17 axis towards the treatment of infectious diabetic wound healing by modified GO-derived biomaterial in mouse models

The Original Article was published on 28 June 2022

Correction: Journal of Nanobiotechnology (2022) 20:309 https://doi.org/10.1186/s12951-022-01516-4

Following publication of the original article [1], the authors identified an error in Figs. 2 and 5. The correct version of figures 2 and 5 are provided in this correction.

Fig. 2
figure 2

Biocompatibility of PEP@GO compared with PEP and control group. A CCK-8 assay results of HUVEC proliferation after treatments at 0, 24, 48 and 72 h. B Live/Dead staining of HUVECs cultured on day 1. Green and red fluorescent cells are viable and dead, respectively. Scale bar: 50 μm. C, D Normal and HG were constructed on the back skin of each mouse. Digital pictures were collected at Day 0, 3, 7, 10 and 14, and its statistical data, minor ticks’ interval: 1 mm. E H&E staining and F Masson staining images of skin section collected from wound area of each group at Day 14, scale bar: 200 μm. Data are the means ± SD three independent experiments. *p < 0.001

Fig. 5
figure 5

Wound healing assays were constructed on the back skin of each mouse in the six groups. AC Representative digital pictures were collected at Day 0, 3, 7, 10 and 14 in the wound healing process and its statistical data, minor ticks’ interval: 1 mm. D H&E staining. E Masson staining images of skin sections of the six groups at Day 14. Scale bar: 200 μm. F qPCR results of the relative miR-21-5p level in the tissues of the six groups at Day 14. *p < 0.001

The original article [1] has been corrected.

Reference

  1. Chen X, Peng Y, Xue H, Liu G, Wang N, Shao Z. MiR-21 regulating PVT1/PTEN/IL-17 axis towards the treatment of infectious diabetic wound healing by modifed GO-derived biomaterial in mouse models. J Nanobiotechnol. 2022;20:309. https://doi.org/10.1186/s12951-022-01516-4.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ning Wang or Zengwu Shao.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chen, X., Peng, Y., Xue, H. et al. Correction: MiR-21 regulating PVT1/PTEN/IL-17 axis towards the treatment of infectious diabetic wound healing by modified GO-derived biomaterial in mouse models. J Nanobiotechnol 21, 8 (2023). https://doi.org/10.1186/s12951-022-01722-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12951-022-01722-0